A6661
Albumin, dinitrophenyl
lyophilized powder
Synonym(s):
DNP-albumin human
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Biological source:
human
Form:
lyophilized powder
Technique(s):
RNA extraction: suitable
Impurities:
Infectious agents, tested
biological source
human
Quality Level
form
lyophilized powder
extent of labeling
30-40 mol DNP per mol albumin
technique(s)
RNA extraction: suitable
impurities
Infectious agents, tested
UniProt accession no.
storage temp.
2-8°C
SMILES string
FC(F)(F)C(F)(F)C(F)(F)F
InChI
1S/C3F8/c4-1(5,2(6,7)8)3(9,10)11
InChI key
QYSGYZVSCZSLHT-UHFFFAOYSA-N
Gene Information
human ... ALB(213)
Application
Albumin, dinitrophenyl has been used to assess degranulation from rat mast cells by treatment of:
- bakkenolide B
- 4-Hydroxy-2-(4-hydroxyphenethyl)isoindoline-1,3-dione (PD1)
- mifepristone
Used for detection in immunological analyses. Can be used as an immunological challenge to activate basophils via the IgE receptor.
Analysis Note
Source material has tested negative for HIV and HBsAg
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
高风险级别生物产品--人源产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Carolin N Zorn et al.
Scientific reports, 8(1), 15467-15467 (2018-10-21)
Antigen (Ag)-mediated crosslinking of IgE-loaded high-affinity receptors for IgE (FcεRI) on mast cells (MCs) triggers activation of proinflammatory effector functions relevant for IgE-associated allergic disorders. The cytosolic tyrosine kinase BTK and the SH2-containing inositol-5'-phosphatase SHIP1 are central positive and negative
Little, S.R. and Eisen, H.N.
Methods Immunol. Immunochem., 1, 128-128 (1967)
Xuan Che et al.
International journal of medical sciences, 17(2), 224-233 (2020-02-11)
Background: Adenomyosis is a quite common gynecological disorder and above 30% of patients have typical secondary and progressive dysmenorrhea. Current treatments still have many disadvantages and thereby the novel treatment aiming to relieve dysmenorrhea still needs to be further investigated.
Global Trade Item Number
| SKU | GTIN |
|---|---|
| A6661-100MG | 04061833382615 |